Immunotherapy eliminates disease-causing cells in mice with MS-like disease. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2022 / 12 / 221205203255.htm ...

U.S. and Chinese researchers appear to have unlocked a novel way to stop T cells from attacking the body in MS and other ...

Plasmacytoid dendritic cells in multiple sclerosis. Plasmacytoid dendritic cells can be activated with viral and bacterial DNA via TLR9. Activated pDCs promote generation of both Th1/Th17 cells ...

According to a 2022 study, the estimated total economic burden of multiple sclerosis in the U.S. was $85.4 billion in 2019, with a direct medical cost of $63.3 billion; indirect and nonmedical ...

Multiple sclerosis (MS) is a chronic disease of the CNS. This disease starts during early adulthood and, despite important advances in treatment in recent years, it remains a leading cause of ...

Building on the growing body of evidence linking EBV to MS, Atara’s EBV T-cell immunotherapy platform aims to leverage the natural attributes of EBV T cells — including trafficking to the site ...

Signs of multiple sclerosis tend to be less severe overall. “TGM-010 is not designed to change inflammation by reducing the number of immune cells to the brain or anything,” she said. “It ...

Saturday, December 28, 2024. News & Perspective Drugs & Diseases CME & Education Video Decision Point Drugs & Diseases CME & Education Video Decision Point ...